A Study to Evaluate the Safety, Tolerability and Efficacy of LB1148 for Subjects Undergoing Elective Bowel Resection
NCT04100447
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
11
Enrollment
OTHER
Sponsor class
Conditions
Adhesions
Ileus
Interventions
DRUG:
Tranexamic Acid
Sponsor
Ronald Hurst, MD, FACS